The present study aims at preparing an Emulgel formulation of Meloxicam using emulsifiers and various gelling agents along with the use of. PDF | Emulgel is one of the recent technologies in NDDS used for dual control release of emulsion and gel for topical use. The stability of. PDF | Topical therapies in cream, ointment, gel and lotion formulation, are an important component of dermatological therapeutic.

Author: Vikus Gunos
Country: Turkmenistan
Language: English (Spanish)
Genre: Photos
Published (Last): 4 September 2010
Pages: 421
PDF File Size: 18.35 Mb
ePub File Size: 19.47 Mb
ISBN: 288-1-98371-394-4
Downloads: 97652
Price: Free* [*Free Regsitration Required]
Uploader: Jurg

Preparation of an emulgel for treatment of aphthous ulcer on the basis of carbomers.

Transdermal controlled release systems. The Complete Drug Reference. The Pharmaceutical Press; This article has been cited by other articles in PMC. Medical Applications of Controlled Release.

There was a problem providing the content you requested

Stability studies showed that the physical appearance, rheological properties, drug release, and antifungal activity in all the prepared emulgels remained unchanged upon storage for 3 months. Received Dec 31; Accepted May Development of a thermoreversible gel for controlled-release ocular fomrulation of diclofenac sodium. Support Center Support Center. Author information Article notes Copyright and License information Disclaimer. Az J Pharm Sci.


Encyclopedia of Pharmaceutical Technology. Formulation and stability of chloramphenicol gel and emulgel. The influence of the type of the gelling agent and the concentration of vormulation the oil phase and emulsifying agent on the drug release from the prepared emulgels was investigated using a 2 3 factorial design.

Optimization of chlorphenesin emulgel formulation

National Center for Biotechnology InformationU. Formulation and evaluation of topical preparations containing phenol and local vesicants. They also exhibited higher drug release and antifungal activity than the CHL powder. As a general conclusion, it was suggested that the CHL emulgel formulation prepared with HPMC with the oil phase concentration in its low level and emulsifying agent concentration in its high level was the formula of choice since it showed the highest drug release and antifungal activity.

The Theory and Practice of Industrial Pharmacy.

Lea and Febiger; The prepared emulgels were evaluated for their physical appearance, rheological behavior, drug release, antifungal activity, and stability.

Commercially available CHL topical powder was used for comparison.

Swarbrick J, Boylan JC, editors. Abstract This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 smulgel of gelling agents: The drug release from all the emulgels was found to follow diffusion-controlled mechanism.


Please review our privacy policy. Marcel Dekker Inc; It was found that the emulsifying agent concentration had the most pronounced effect on the drug release from the emulgels followed by the oil phase concentration and finally the type of the gelling agent.

Analysis of data on the medicament release from ointments. A study of shear and compression deformations on hydrophilic gels of tretinoin. Egypt J Pharm Sci. Rheological studies revealed that the CHL emulgels exhibited a shear-thinning behavior with thixotropy. All the prepared emulgels showed emulgsl physical properties concerning color, homogeneity, consistency, spreadability, and pH value.

Optimization of chlorphenesin emulgel formulation

This study was conducted to develop an emulgel formulation of chlorphenesin CHL using 2 types of gelling agents: Bioavailability of salbutamol sulphate from different suppository formulations.

Published online Sep 1. Blackwell Scientific Publications;

Author: admin